Journey Medical Corp (DERM) Net Cash Provided by (Used in) Financing Activities USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Journey Medical Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2021 to 2024.
  • Journey Medical Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.64 M, a 3048% increase year-over-year.
  • Journey Medical Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$4.8 M, a 129% decline from 2022.
  • Journey Medical Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $16.5 M, a 69% decline from 2021.
  • Journey Medical Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $53 M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.64 M +$1.59 M +3048% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $52 K -$11.3 M -99.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $11.4 M +$1.98 M +21% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q1 2021 $9.39 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.